Emma C. Scott
Oregon Health & Science University(US)Sheba Medical Center(IL)Oregon Health and Science University Hospital(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Amyloidosis: Diagnosis, Treatment, Outcomes, Cancer Treatment and Pharmacology
Most-Cited Works
- → PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma(2014)3,521 cited
- → Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial(2016)843 cited
- → Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy(2019)603 cited
- → Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma(2022)443 cited
- → Combined autophagy and proteasome inhibition(2014)372 cited
- → Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR(2018)257 cited